Effects of propofol, etomidate, midazolam, and fentanyl on motor evoked responses to transcranial electrical or magnetic stimulation in humans.
Identifieur interne : 000314 ( Ncbi/Merge ); précédent : 000313; suivant : 000315Effects of propofol, etomidate, midazolam, and fentanyl on motor evoked responses to transcranial electrical or magnetic stimulation in humans.
Auteurs : C J Kalkman [États-Unis] ; J C Drummond ; A A Ribberink ; P M Patel ; T. Sano ; R G BickfordSource :
- Anesthesiology [ 0003-3022 ] ; 1992.
Descripteurs français
- KwdFr :
- MESH :
- pharmacologie : Fentanyl, Midazolam, Propofol, Étomidate.
- Adulte, Femelle, Humains, Injections veineuses, Magnétisme, Muscles, Mâle, Potentiels évoqués, Stimulation électrique.
English descriptors
- KwdEn :
- MESH :
- chemical , pharmacology : Etomidate, Fentanyl, Midazolam, Propofol.
- drug effects : Evoked Potentials, Muscles.
- Adult, Electric Stimulation, Female, Humans, Injections, Intravenous, Magnetics, Male.
Abstract
The effects of propofol, etomidate, midazolam, and fentanyl on motor evoked responses to transcranial stimulation (tc-MERs) were studied in five healthy human volunteers. Each subject, in four separate sessions, received intravenous bolus doses of propofol 2 mg.kg-1, etomidate 0.3 mg.kg-1, midazolam 0.05 mg.kg-1, and fentanyl 3 micrograms.kg-1. Electrical tc-MERs (tce-MERs) were elicited with anodal stimuli of 500-700 V. Magnetic tc-MERs (tcmag-MERs) were elicited using a Cadwell MES-10 magnetic stimulator at maximum output. Compound muscle action potentials were recorded from the tibialis anterior muscle. Duplicate tce-MERs and tcmag-MERs were recorded before and up to 30 min after drug injection. Reproducible baseline tce-MERs (amplitude 4.7 +/- 0.43 (SEM) mV, latency 29.4 +/- 0.35 ms) and tcmag-MERs (amplitude 3.7 +/- 0.43 mV, latency 31.1 +/- 0.39 ms) were obtained in all subjects. Pronounced depression of tce-MER amplitude to 2% of baseline values (P less than 0.01) was observed 2 min after injection of propofol. Thirty minutes after injection of propofol, amplitude depression to 44% of baseline (P less than 0.05) was still present, despite an apparent lack of sedation. Midazolam caused significant (P less than 0.01) amplitude depression, e.g., tcmag-MER to 16% of baseline values 5 min after injection. Significant depression persisted throughout the 30-min study period. Fentanyl did not cause any statistically significant amplitude changes in this small population. Etomidate caused significant but transient depression of tc-MER amplitude. However, there was considerable intersubject variability. Latency did not change significantly after any drug.(ABSTRACT TRUNCATED AT 250 WORDS)
DOI: 10.1097/00000542-199204000-00003
PubMed: 1550274
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002962
- to stream PubMed, to step Curation: 002962
- to stream PubMed, to step Checkpoint: 002813
Links to Exploration step
pubmed:1550274Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effects of propofol, etomidate, midazolam, and fentanyl on motor evoked responses to transcranial electrical or magnetic stimulation in humans.</title>
<author><name sortKey="Kalkman, C J" sort="Kalkman, C J" uniqKey="Kalkman C" first="C J" last="Kalkman">C J Kalkman</name>
<affiliation wicri:level="3"><nlm:affiliation>University of California, San Diego.</nlm:affiliation>
<country>États-Unis</country>
<placeName><settlement type="city">San Diego</settlement>
<region type="state">Californie</region>
</placeName>
<wicri:orgArea>University of California</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Drummond, J C" sort="Drummond, J C" uniqKey="Drummond J" first="J C" last="Drummond">J C Drummond</name>
</author>
<author><name sortKey="Ribberink, A A" sort="Ribberink, A A" uniqKey="Ribberink A" first="A A" last="Ribberink">A A Ribberink</name>
</author>
<author><name sortKey="Patel, P M" sort="Patel, P M" uniqKey="Patel P" first="P M" last="Patel">P M Patel</name>
</author>
<author><name sortKey="Sano, T" sort="Sano, T" uniqKey="Sano T" first="T" last="Sano">T. Sano</name>
</author>
<author><name sortKey="Bickford, R G" sort="Bickford, R G" uniqKey="Bickford R" first="R G" last="Bickford">R G Bickford</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1992">1992</date>
<idno type="RBID">pubmed:1550274</idno>
<idno type="pmid">1550274</idno>
<idno type="doi">10.1097/00000542-199204000-00003</idno>
<idno type="wicri:Area/PubMed/Corpus">002962</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002962</idno>
<idno type="wicri:Area/PubMed/Curation">002962</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002962</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002813</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002813</idno>
<idno type="wicri:Area/Ncbi/Merge">000314</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Effects of propofol, etomidate, midazolam, and fentanyl on motor evoked responses to transcranial electrical or magnetic stimulation in humans.</title>
<author><name sortKey="Kalkman, C J" sort="Kalkman, C J" uniqKey="Kalkman C" first="C J" last="Kalkman">C J Kalkman</name>
<affiliation wicri:level="3"><nlm:affiliation>University of California, San Diego.</nlm:affiliation>
<country>États-Unis</country>
<placeName><settlement type="city">San Diego</settlement>
<region type="state">Californie</region>
</placeName>
<wicri:orgArea>University of California</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Drummond, J C" sort="Drummond, J C" uniqKey="Drummond J" first="J C" last="Drummond">J C Drummond</name>
</author>
<author><name sortKey="Ribberink, A A" sort="Ribberink, A A" uniqKey="Ribberink A" first="A A" last="Ribberink">A A Ribberink</name>
</author>
<author><name sortKey="Patel, P M" sort="Patel, P M" uniqKey="Patel P" first="P M" last="Patel">P M Patel</name>
</author>
<author><name sortKey="Sano, T" sort="Sano, T" uniqKey="Sano T" first="T" last="Sano">T. Sano</name>
</author>
<author><name sortKey="Bickford, R G" sort="Bickford, R G" uniqKey="Bickford R" first="R G" last="Bickford">R G Bickford</name>
</author>
</analytic>
<series><title level="j">Anesthesiology</title>
<idno type="ISSN">0003-3022</idno>
<imprint><date when="1992" type="published">1992</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Electric Stimulation</term>
<term>Etomidate (pharmacology)</term>
<term>Evoked Potentials (drug effects)</term>
<term>Female</term>
<term>Fentanyl (pharmacology)</term>
<term>Humans</term>
<term>Injections, Intravenous</term>
<term>Magnetics</term>
<term>Male</term>
<term>Midazolam (pharmacology)</term>
<term>Muscles (drug effects)</term>
<term>Propofol (pharmacology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Femelle</term>
<term>Fentanyl (pharmacologie)</term>
<term>Humains</term>
<term>Injections veineuses</term>
<term>Magnétisme</term>
<term>Midazolam (pharmacologie)</term>
<term>Muscles ()</term>
<term>Mâle</term>
<term>Potentiels évoqués ()</term>
<term>Propofol (pharmacologie)</term>
<term>Stimulation électrique</term>
<term>Étomidate (pharmacologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Etomidate</term>
<term>Fentanyl</term>
<term>Midazolam</term>
<term>Propofol</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Evoked Potentials</term>
<term>Muscles</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Fentanyl</term>
<term>Midazolam</term>
<term>Propofol</term>
<term>Étomidate</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Electric Stimulation</term>
<term>Female</term>
<term>Humans</term>
<term>Injections, Intravenous</term>
<term>Magnetics</term>
<term>Male</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Femelle</term>
<term>Humains</term>
<term>Injections veineuses</term>
<term>Magnétisme</term>
<term>Muscles</term>
<term>Mâle</term>
<term>Potentiels évoqués</term>
<term>Stimulation électrique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The effects of propofol, etomidate, midazolam, and fentanyl on motor evoked responses to transcranial stimulation (tc-MERs) were studied in five healthy human volunteers. Each subject, in four separate sessions, received intravenous bolus doses of propofol 2 mg.kg-1, etomidate 0.3 mg.kg-1, midazolam 0.05 mg.kg-1, and fentanyl 3 micrograms.kg-1. Electrical tc-MERs (tce-MERs) were elicited with anodal stimuli of 500-700 V. Magnetic tc-MERs (tcmag-MERs) were elicited using a Cadwell MES-10 magnetic stimulator at maximum output. Compound muscle action potentials were recorded from the tibialis anterior muscle. Duplicate tce-MERs and tcmag-MERs were recorded before and up to 30 min after drug injection. Reproducible baseline tce-MERs (amplitude 4.7 +/- 0.43 (SEM) mV, latency 29.4 +/- 0.35 ms) and tcmag-MERs (amplitude 3.7 +/- 0.43 mV, latency 31.1 +/- 0.39 ms) were obtained in all subjects. Pronounced depression of tce-MER amplitude to 2% of baseline values (P less than 0.01) was observed 2 min after injection of propofol. Thirty minutes after injection of propofol, amplitude depression to 44% of baseline (P less than 0.05) was still present, despite an apparent lack of sedation. Midazolam caused significant (P less than 0.01) amplitude depression, e.g., tcmag-MER to 16% of baseline values 5 min after injection. Significant depression persisted throughout the 30-min study period. Fentanyl did not cause any statistically significant amplitude changes in this small population. Etomidate caused significant but transient depression of tc-MER amplitude. However, there was considerable intersubject variability. Latency did not change significantly after any drug.(ABSTRACT TRUNCATED AT 250 WORDS)</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">1550274</PMID>
<DateCompleted><Year>1992</Year>
<Month>04</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>06</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0003-3022</ISSN>
<JournalIssue CitedMedium="Print"><Volume>76</Volume>
<Issue>4</Issue>
<PubDate><Year>1992</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Anesthesiology</Title>
<ISOAbbreviation>Anesthesiology</ISOAbbreviation>
</Journal>
<ArticleTitle>Effects of propofol, etomidate, midazolam, and fentanyl on motor evoked responses to transcranial electrical or magnetic stimulation in humans.</ArticleTitle>
<Pagination><MedlinePgn>502-9</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The effects of propofol, etomidate, midazolam, and fentanyl on motor evoked responses to transcranial stimulation (tc-MERs) were studied in five healthy human volunteers. Each subject, in four separate sessions, received intravenous bolus doses of propofol 2 mg.kg-1, etomidate 0.3 mg.kg-1, midazolam 0.05 mg.kg-1, and fentanyl 3 micrograms.kg-1. Electrical tc-MERs (tce-MERs) were elicited with anodal stimuli of 500-700 V. Magnetic tc-MERs (tcmag-MERs) were elicited using a Cadwell MES-10 magnetic stimulator at maximum output. Compound muscle action potentials were recorded from the tibialis anterior muscle. Duplicate tce-MERs and tcmag-MERs were recorded before and up to 30 min after drug injection. Reproducible baseline tce-MERs (amplitude 4.7 +/- 0.43 (SEM) mV, latency 29.4 +/- 0.35 ms) and tcmag-MERs (amplitude 3.7 +/- 0.43 mV, latency 31.1 +/- 0.39 ms) were obtained in all subjects. Pronounced depression of tce-MER amplitude to 2% of baseline values (P less than 0.01) was observed 2 min after injection of propofol. Thirty minutes after injection of propofol, amplitude depression to 44% of baseline (P less than 0.05) was still present, despite an apparent lack of sedation. Midazolam caused significant (P less than 0.01) amplitude depression, e.g., tcmag-MER to 16% of baseline values 5 min after injection. Significant depression persisted throughout the 30-min study period. Fentanyl did not cause any statistically significant amplitude changes in this small population. Etomidate caused significant but transient depression of tc-MER amplitude. However, there was considerable intersubject variability. Latency did not change significantly after any drug.(ABSTRACT TRUNCATED AT 250 WORDS)</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kalkman</LastName>
<ForeName>C J</ForeName>
<Initials>CJ</Initials>
<AffiliationInfo><Affiliation>University of California, San Diego.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Drummond</LastName>
<ForeName>J C</ForeName>
<Initials>JC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ribberink</LastName>
<ForeName>A A</ForeName>
<Initials>AA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Patel</LastName>
<ForeName>P M</ForeName>
<Initials>PM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Sano</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bickford</LastName>
<ForeName>R G</ForeName>
<Initials>RG</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Anesthesiology</MedlineTA>
<NlmUniqueID>1300217</NlmUniqueID>
<ISSNLinking>0003-3022</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>R60L0SM5BC</RegistryNumber>
<NameOfSubstance UI="D008874">Midazolam</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>UF599785JZ</RegistryNumber>
<NameOfSubstance UI="D005283">Fentanyl</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>YI7VU623SF</RegistryNumber>
<NameOfSubstance UI="D015742">Propofol</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>Z22628B598</RegistryNumber>
<NameOfSubstance UI="D005045">Etomidate</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>AIM</CitationSubset>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004558" MajorTopicYN="N">Electric Stimulation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005045" MajorTopicYN="N">Etomidate</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005071" MajorTopicYN="N">Evoked Potentials</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005283" MajorTopicYN="N">Fentanyl</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007275" MajorTopicYN="N">Injections, Intravenous</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008280" MajorTopicYN="N">Magnetics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008874" MajorTopicYN="N">Midazolam</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009132" MajorTopicYN="N">Muscles</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015742" MajorTopicYN="N">Propofol</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year>
<Month>4</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1992</Year>
<Month>4</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1992</Year>
<Month>4</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">1550274</ArticleId>
<ArticleId IdType="doi">10.1097/00000542-199204000-00003</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
</region>
<settlement><li>San Diego</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Bickford, R G" sort="Bickford, R G" uniqKey="Bickford R" first="R G" last="Bickford">R G Bickford</name>
<name sortKey="Drummond, J C" sort="Drummond, J C" uniqKey="Drummond J" first="J C" last="Drummond">J C Drummond</name>
<name sortKey="Patel, P M" sort="Patel, P M" uniqKey="Patel P" first="P M" last="Patel">P M Patel</name>
<name sortKey="Ribberink, A A" sort="Ribberink, A A" uniqKey="Ribberink A" first="A A" last="Ribberink">A A Ribberink</name>
<name sortKey="Sano, T" sort="Sano, T" uniqKey="Sano T" first="T" last="Sano">T. Sano</name>
</noCountry>
<country name="États-Unis"><region name="Californie"><name sortKey="Kalkman, C J" sort="Kalkman, C J" uniqKey="Kalkman C" first="C J" last="Kalkman">C J Kalkman</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000314 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000314 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:1550274 |texte= Effects of propofol, etomidate, midazolam, and fentanyl on motor evoked responses to transcranial electrical or magnetic stimulation in humans. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:1550274" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |